These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 15936882
1. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Costa B, Trovato AE, Colleoni M, Giagnoni G, Zarini E, Croci T. Pain; 2005 Jul; 116(1-2):52-61. PubMed ID: 15936882 [Abstract] [Full Text] [Related]
2. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. Eur J Pharmacol; 2007 Feb 05; 556(1-3):75-83. PubMed ID: 17157290 [Abstract] [Full Text] [Related]
3. Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice. Comelli F, Bettoni I, Colombo A, Fumagalli P, Giagnoni G, Costa B. Eur J Pharmacol; 2010 Jul 10; 637(1-3):62-9. PubMed ID: 20399204 [Abstract] [Full Text] [Related]
4. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms. Wen J, Jones M, Tanaka M, Selvaraj P, Symes AJ, Cox B, Zhang Y. J Neuroinflammation; 2018 Jan 08; 15(1):9. PubMed ID: 29310667 [Abstract] [Full Text] [Related]
5. A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury. Khalil Z, Khodr B. Free Radic Biol Med; 2001 Aug 15; 31(4):430-9. PubMed ID: 11498276 [Abstract] [Full Text] [Related]
6. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S. Eur J Neurosci; 2006 Oct 15; 24(7):2011-20. PubMed ID: 17040473 [Abstract] [Full Text] [Related]
8. Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain. Becker A, Geisslinger G, Murín R, Grecksch G, Höllt V, Zimmer A, Schröder H. Naunyn Schmiedebergs Arch Pharmacol; 2013 May 15; 386(5):369-82. PubMed ID: 23371449 [Abstract] [Full Text] [Related]
9. Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents. Croci T, Landi M, Galzin AM, Marini P. Br J Pharmacol; 2003 Sep 15; 140(1):115-22. PubMed ID: 12967941 [Abstract] [Full Text] [Related]
10. Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in rats. Gong D, Geng C, Jiang L, Aoki Y, Nakano M, Zhong L. Eur J Pharmacol; 2012 Dec 15; 697(1-3):53-8. PubMed ID: 23063836 [Abstract] [Full Text] [Related]
11. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Costa B, Colleoni M, Conti S, Trovato AE, Bianchi M, Sotgiu ML, Giagnoni G. Br J Pharmacol; 2004 Jan 15; 141(1):4-8. PubMed ID: 14662732 [Abstract] [Full Text] [Related]
12. Exercise training attenuates neuropathic pain and cytokine expression after chronic constriction injury of rat sciatic nerve. Chen YW, Li YT, Chen YC, Li ZY, Hung CH. Anesth Analg; 2012 Jun 15; 114(6):1330-7. PubMed ID: 22415536 [Abstract] [Full Text] [Related]
14. Nitric oxide and its modulators in chronic constriction injury-induced neuropathic pain in rats. Naik AK, Tandan SK, Kumar D, Dudhgaonkar SP. Eur J Pharmacol; 2006 Jan 13; 530(1-2):59-69. PubMed ID: 16364289 [Abstract] [Full Text] [Related]
15. Hyperbaric oxygenation therapy alleviates chronic constrictive injury-induced neuropathic pain and reduces tumor necrosis factor-alpha production. Li F, Fang L, Huang S, Yang Z, Nandi J, Thomas S, Chen C, Camporesi E. Anesth Analg; 2011 Sep 13; 113(3):626-33. PubMed ID: 21596875 [Abstract] [Full Text] [Related]
16. Development and expression of neuropathic pain in CB1 knockout mice. Castañé A, Célérier E, Martín M, Ledent C, Parmentier M, Maldonado R, Valverde O. Neuropharmacology; 2006 Jan 13; 50(1):111-22. PubMed ID: 16169563 [Abstract] [Full Text] [Related]
17. Deficiency of the negative immune regulator B7-H1 enhances inflammation and neuropathic pain after chronic constriction injury of mouse sciatic nerve. Uçeyler N, Göbel K, Meuth SG, Ortler S, Stoll G, Sommer C, Wiendl H, Kleinschnitz C. Exp Neurol; 2010 Mar 13; 222(1):153-60. PubMed ID: 20051242 [Abstract] [Full Text] [Related]
18. Effects of repeated administered ghrelin on chronic constriction injury of the sciatic nerve in rats. Guneli E, Onal A, Ates M, Bagriyanik HA, Resmi H, Orhan CE, Kolatan HE, Gumustekin M. Neurosci Lett; 2010 Aug 02; 479(3):226-30. PubMed ID: 20561937 [Abstract] [Full Text] [Related]
19. Behavioral and histological effects of endoneurial administration of nerve growth factor: possible implications in neuropathic pain. Ruiz G, Ceballos D, Baños JE. Brain Res; 2004 Jun 11; 1011(1):1-6. PubMed ID: 15140639 [Abstract] [Full Text] [Related]
20. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G. Br J Pharmacol; 2006 Aug 11; 148(7):1022-32. PubMed ID: 16770320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]